TSX News -
Trillium Reports First Quarter 2017 Financial and Operating Results
TORONTO, ONTARIO–(Marketwired – May 12, 2017) – Trillium Therapeutics Inc. (TSX:TRIL)(NASDAQ:TRIL), a clinical stage immuno-oncology company developing innovative therapies for [...]